author-photo

Katy L. Simonsen

Bristol-Myers Squibb

7

Papers

205

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Multi-arm multi-stage clinical trials for time-to-event outcomes.

2021 Journal of Biopharmaceutical Statistics
Show All
- Source
- Cite
- Save
Citations (0)
Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047 (CA224-047).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (13)
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (8)
P226 FRACTION-RCC: a randomized, open-label, adaptive, phase 2 study of nivolumab in combination with other immuno-oncology agents in patients with advanced RCC.

2017 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase 2, fast real-time assessment of combination therapies in immuno-oncology trial in patients with advanced non-small cell lung cancer (FRACTION-lung)

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study

2008 Journal of the American College of Cardiology
Show All
- Source
- Cite
- Save
Citations (144)
Association Between ADAMTS1 Matrix Metalloproteinase Gene Variation, Coronary Heart Disease, and Benefit of Statin Therapy

2008 Arteriosclerosis, Thrombosis, and Vascular Biology
Show All
- Source
- Cite
- Save
Citations (39)